To provide qualitative assessment of platelet function in patients on platelet inhibitor drugs, particularly clopidogrel, prasugrel, ticagrelor or cangrelor. For patients on these drugs or have recently discontinued them, PlateletMapping ADP on TEG6s may help assess adequacy of platelet function and risk for excessive bleeding prior to cardiovascular surgery or other surgical procedures with risk for high blood loss.